Guangdong China Resources Shunfeng Pharmaceutical Co., Ltd.

China Resources Shunfeng Pharmaceutical is a wholly-owned subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (stock code: 000999) under China Resources National Corporation. It is a modern pharmaceutical enterprise mainly engaged in the production of external-use drugs, a national key high-tech enterprise, a undertaking unit of the National Major Special Project 863 Program, the Guangdong Provincial Engineering Technology Research and Development Center for External-Use Drugs, and the undertaking unit of the Guangdong Provincial Academician Expert Workstation Project. China Resources Shunfeng was founded in 1969, with a factory building or other land area of approximately 29,000 square meters. Through continuous development and transformation, the enterprise has become capable of producing ointments, creams, gels, tablets, active pharmaceutical ingredients, and children's and adult series pharmaceutical and care products, forming a modern comprehensive pharmaceutical enterprise primarily focused on external-use drugs while diversifying its product structure. The company's pharmaceutical research center is one of the research institutes with strong research and development capabilities among domestic pharmaceutical manufacturers. Over the past decade or more, it has successfully researched and developed: 28 new drugs of former national categories 1-6, 8 functional cosmetics, 17 infant and child cosmetics, 6 health foods, and 3 other new products, and has obtained 15 authorized national invention patents. In 2017, an academician expert workstation was established, and multiple industry-university-research projects have been successively carried out with universities and research institutions such as Sun Yat-sen University, Guangdong Provincial Hospital of Chinese Medicine, Xinhua Hospital Affiliated to Fudan University, and Shenyang Pharmaceutical University. In 2019 and 2021, joint laboratories were respectively established with Shanghai Jiao Tong University School of Medicine and Southern Medical University Dermatology Hospital, forming an innovation and transformation platform for "industry-university-research" medical skincare products to support category development. In early 2020, skin barrier repair series products for infants, children and adults were successfully launched. The company currently has 349 employees, with 70% holding a college degree or above. It has a sound grassroots Party organization, with the general Party branch having 2 branches, currently with 47 Party members, 76% of whom hold a bachelor's degree or above.